Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Accelerate Diagnosti (AXDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,255,816
  • Shares Outstanding, K 54,130
  • Annual Sales, $ 4,180 K
  • Annual Income, $ -64,030 K
  • 36-Month Beta 2.20
  • Price/Sales 292.22
  • Price/Cash Flow N/A
  • Price/Book 12.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.44
  • Number of Estimates 3
  • High Estimate -0.40
  • Low Estimate -0.48
  • Prior Year -0.31
  • Growth Rate Est. (year over year) -41.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.35 +14.00%
on 09/14/18
24.75 -6.26%
on 08/31/18
+0.05 (+0.22%)
since 08/24/18
3-Month
19.85 +16.88%
on 08/07/18
24.75 -6.26%
on 08/31/18
-0.80 (-3.33%)
since 06/22/18
52-Week
16.75 +38.51%
on 11/03/17
30.35 -23.56%
on 01/26/18
+0.50 (+2.20%)
since 09/22/17

Most Recent Stories

More News
Top 5 Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (CBM , AXDX , NEO , BRKR , PRAH )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

AXDX : 23.20 (+2.88%)
NEO : 14.55 (+2.46%)
CBM : 63.00 (+2.94%)
Notable Wednesday Option Activity: AXDX, WSM, USCR

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Accelerate Diagnostics Inc , where a total of 789 contracts have traded so far, representing...

AXDX : 23.20 (+2.88%)
Accelerate Diagnostics Receives New Innovative Technology Contract from Vizient for the Accelerate Pheno(TM) System

Accelerate Diagnostics, Inc. announced today that it received an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the United States....

AXDX : 23.20 (+2.88%)
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates

Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of -16.22% and -22.03%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?...

AXDX : 23.20 (+2.88%)
Accelerate Diagnostics: 2Q Earnings Snapshot

TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Monday reported a loss of $23.2 million in its second quarter.

AXDX : 23.20 (+2.88%)
Accelerate Diagnostics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 6, 2018 / Accelerate Diagnostics, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 6, 2018 at 4:15 PM Eastern...

AXDX : 23.20 (+2.88%)
Accelerate Diagnostics to Review Second Quarter 2018 Results on August 6th

Accelerate Diagnostics, Inc. announced today it will host a conference call on Monday, August 6, 2018 to review the company's second quarter 2018 financial results and commercial progress.

AXDX : 23.20 (+2.88%)
Accelerate Diagnostics: 1Q Earnings Snapshot

TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Wednesday reported a loss of $20.8 million in its first quarter.

AXDX : 23.20 (+2.88%)
Accelerate Diagnostics reports Q1 2018 financial results

Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018. The company generated revenue of $801,000, up 51% from the prior year, and reported signed agreements...

AXDX : 23.20 (+2.88%)
Report: Developing Opportunities within US Ecology, Universal Health Realty Income Trust, Accelerate Diagnostics, Chesapeake Lodging Trust, Super Micro Computer, and Choice Hotels International -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of US Ecology, Inc. (NASDAQ:ECOL),...

UHT : 70.84 (-2.32%)
CHH : 82.75 (-0.54%)
AXDX : 23.20 (+2.88%)
SMCI : 19.9100 (-3.82%)
ECOL : 75.70 (-1.11%)
CHSP : 32.67 (-1.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade AXDX with:

Business Summary

Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections...

See More

Key Turning Points

2nd Resistance Point 24.43
1st Resistance Point 23.82
Last Price 23.20
1st Support Level 22.37
2nd Support Level 21.53

See More

52-Week High 30.35
Fibonacci 61.8% 25.15
Fibonacci 50% 23.55
Last Price 23.20
Fibonacci 38.2% 21.95
52-Week Low 16.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar